214 related articles for article (PubMed ID: 17249204)
21. The accurate staging of ovarian cancer using 3T magnetic resonance imaging--a realistic option.
Booth SJ; Turnbull LW; Poole DR; Richmond I
BJOG; 2008 Jun; 115(7):894-901. PubMed ID: 18485169
[TBL] [Abstract][Full Text] [Related]
22. Epithelial ovarian tumors: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis.
Thomassin-Naggara I; Bazot M; Daraï E; Callard P; Thomassin J; Cuenod CA
Radiology; 2008 Jul; 248(1):148-59. PubMed ID: 18458244
[TBL] [Abstract][Full Text] [Related]
23. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
[TBL] [Abstract][Full Text] [Related]
24. Metastatic liver tumor from cystic ovarian carcinomas: CT and MRI appearance.
Tang Y; Yamashita Y; Ogata I; Namimoto T; Abe Y; Urata J; Takahashi M
Radiat Med; 1999; 17(4):265-70. PubMed ID: 10510898
[TBL] [Abstract][Full Text] [Related]
25. Treated ovarian cancer: MR imaging, laparotomy reassessment, and serum CA-125 values compared with clinical outcome at 1 year.
Low RN; Duggan B; Barone RM; Saleh F; Song SY
Radiology; 2005 Jun; 235(3):918-26. PubMed ID: 15914479
[TBL] [Abstract][Full Text] [Related]
26. ESUR recommendations for MR imaging of the sonographically indeterminate adnexal mass: an update.
Forstner R; Thomassin-Naggara I; Cunha TM; Kinkel K; Masselli G; Kubik-Huch R; Spencer JA; Rockall A
Eur Radiol; 2017 Jun; 27(6):2248-2257. PubMed ID: 27770228
[TBL] [Abstract][Full Text] [Related]
27. Preliminary observations and clinical value of N-acetyl resonances in ovarian tumours using in-vivo proton MR spectroscopy at 3T.
Takeuchi M; Matsuzaki K; Harada M
Eur Radiol; 2011 Dec; 21(12):2640-6. PubMed ID: 21818526
[TBL] [Abstract][Full Text] [Related]
28. Is MRI a useful tool to distinguish between serous and mucinous borderline ovarian tumours?
Bazot M; Haouy D; Daraï E; Cortez A; Dechoux-Vodovar S; Thomassin-Naggara I
Clin Radiol; 2013 Jan; 68(1):e1-8. PubMed ID: 23044365
[TBL] [Abstract][Full Text] [Related]
29. Comparison of 2-dimensional and 3-dimensional power-Doppler imaging in complex adnexal masses for the prediction of ovarian cancer.
Alcázar JL; Castillo G
Am J Obstet Gynecol; 2005 Mar; 192(3):807-12. PubMed ID: 15746675
[TBL] [Abstract][Full Text] [Related]
30. MR imaging of soft-tissue masses: diagnostic efficacy and value of distinguishing between benign and malignant lesions.
Moulton JS; Blebea JS; Dunco DM; Braley SE; Bisset GS; Emery KH
AJR Am J Roentgenol; 1995 May; 164(5):1191-9. PubMed ID: 7717231
[TBL] [Abstract][Full Text] [Related]
31. Malignant or borderline mucinous cystic neoplasms have a larger number of loculi than mucinous cystadenoma: a retrospective study with MR.
Okamoto Y; Tanaka YO; Tsunoda H; Yoshikawa H; Minami M
J Magn Reson Imaging; 2007 Jul; 26(1):94-9. PubMed ID: 17659568
[TBL] [Abstract][Full Text] [Related]
32. Prospective evaluation of 3T MRI findings for primary adnexal lesions and comparison with the final histological diagnosis.
Zhang H; Zhang GF; He ZY; Li ZY; Zhang GX
Arch Gynecol Obstet; 2014 Feb; 289(2):357-64. PubMed ID: 23934242
[TBL] [Abstract][Full Text] [Related]
33. Characterization of adrenal masses using MR imaging with histopathologic correlation.
Heinz-Peer G; Hönigschnabl S; Schneider B; Niederle B; Kaserer K; Lechner G
AJR Am J Roentgenol; 1999 Jul; 173(1):15-22. PubMed ID: 10397092
[TBL] [Abstract][Full Text] [Related]
34. Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging.
Hecht EM; Israel GM; Krinsky GA; Hahn WY; Kim DC; Belitskaya-Levy I; Lee VS
Radiology; 2004 Aug; 232(2):373-8. PubMed ID: 15215544
[TBL] [Abstract][Full Text] [Related]
35. Role of laparoscopy in the diagnosis and treatment of adnexal masses.
Leng JH; Lang JH; Zhang JJ; Feng FZ; Liu ZF; Sun DW; Zhu L; Zhao XY
Chin Med J (Engl); 2006 Feb; 119(3):202-6. PubMed ID: 16537005
[TBL] [Abstract][Full Text] [Related]
36. Value of ultrasound and magnetic resonance imaging in the preoperative evaluation of suspected ovarian masses.
Huber S; Medl M; Baumann L; Czembirek H
Anticancer Res; 2002; 22(4):2501-7. PubMed ID: 12174952
[TBL] [Abstract][Full Text] [Related]
37. [Accuracy of frozen section in diagnosis of ovarian tumors].
Zhang GN
Zhonghua Fu Chan Ke Za Zhi; 1993 Oct; 28(10):601-3, 635. PubMed ID: 8112130
[TBL] [Abstract][Full Text] [Related]
38. MR imaging in the characterization of small renal masses.
Willatt JM; Hussain HK; Chong S; Kappil M; Azar SF; Liu PS; Ruma JA; Elsayes KM
Abdom Imaging; 2014 Aug; 39(4):761-9. PubMed ID: 24615511
[TBL] [Abstract][Full Text] [Related]
39. Developing an MR imaging strategy for diagnosis of ovarian masses.
Imaoka I; Wada A; Kaji Y; Hayashi T; Hayashi M; Matsuo M; Sugimura K
Radiographics; 2006; 26(5):1431-48. PubMed ID: 16973774
[TBL] [Abstract][Full Text] [Related]
40. Serum C-reactive protein in the differential diagnosis of ovarian masses.
Hefler-Frischmuth K; Hefler LA; Heinze G; Paseka V; Grimm C; Tempfer CB
Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):65-8. PubMed ID: 19619929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
